Oligonucleotides are short nucleic acid polymers used in research, genetic testing and forensics.
Oligonucleotides are usually made up of 13 to 25 nucleotides and are designed to hybridize specifically to DNA or RNA sequences. Solid-phase clinical synthesis is used to manufacture these small bits of nucleic acid for use in polymerase chain reaction (PCR), DNA sequencing, library construction and artificial gene synthesis.
The global Oligonucleotide market is projected to grow from US$ 1399.7 million in 2023 to US$ 2493.1 million by 2029, at a Compound Annual Growth Rate (CAGR) of 10.1% during the forecast period.
Global Oligonucleotides key players include Integrated DNA Technologies, Agilent, Sigma-aldrich, Eurofins Genomics, L.G.C Biosearch Technologies, etc. Global top five manufacturers hold a share over 45%.
North America is the largest market, with a share over 35%, followed by Europe and China, both have a share over 35percent.
In terms of product, DNA Oligos is the largest segment, with a share over 65%. And in terms of application, the largest application is Research, followed by Pharmaceutical.
In terms of production side, this report researches the Oligonucleotide production, growth rate, market share by manufacturers and by region (region level and country level), from 2018 to 2023, and forecast to 2029.
In terms of consumption side, this report focuses on the sales of Oligonucleotide by region (region level and country level), by company, by Type and by Application. from 2018 to 2023 and forecast to 2029.
Report Includes:
This report presents an overview of global market for Oligonucleotide, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Oligonucleotide, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Oligonucleotide, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Oligonucleotide sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Oligonucleotide market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Oligonucleotide sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Abbott Molecular, PerkinElmer, SciGene Corporation, Roche NimbleGen and CytoTest, etc.
By Company
Abbott Molecular
PerkinElmer
SciGene Corporation
Roche NimbleGen
CytoTest
Segment by Type
DNA
RNA
Segment by Application
Gene Chip
Electrophoresis
Fluorescence In Situ Hybridization
Production by Region
North America
Europe
China
Japan
Sales by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Oligonucleotide production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Oligonucleotide in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Oligonucleotide manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 8: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 9: China by type and by application sales and revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oligonucleotide sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Oligonucleotide Product Introduction
1.2 麻豆原创 by Type
1.2.1 Global Oligonucleotide 麻豆原创 Size by Type, 2018 VS 2022 VS 2029
1.2.2 DNA
1.2.3 RNA
1.3 麻豆原创 by Application
1.3.1 Global Oligonucleotide 麻豆原创 Size by Application, 2018 VS 2022 VS 2029
1.3.2 Gene Chip
1.3.3 Electrophoresis
1.3.4 Fluorescence In Situ Hybridization
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Oligonucleotide Production
2.1 Global Oligonucleotide Production Capacity (2018-2029)
2.2 Global Oligonucleotide Production by Region: 2018 VS 2022 VS 2029
2.3 Global Oligonucleotide Production by Region
2.3.1 Global Oligonucleotide Historic Production by Region (2018-2023)
2.3.2 Global Oligonucleotide Forecasted Production by Region (2024-2029)
2.3.3 Global Oligonucleotide Production 麻豆原创 Share by Region (2018-2029)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Executive Summary
3.1 Global Oligonucleotide Revenue Estimates and Forecasts 2018-2029
3.2 Global Oligonucleotide Revenue by Region
3.2.1 Global Oligonucleotide Revenue by Region: 2018 VS 2022 VS 2029
3.2.2 Global Oligonucleotide Revenue by Region (2018-2023)
3.2.3 Global Oligonucleotide Revenue by Region (2024-2029)
3.2.4 Global Oligonucleotide Revenue 麻豆原创 Share by Region (2018-2029)
3.3 Global Oligonucleotide Sales Estimates and Forecasts 2018-2029
3.4 Global Oligonucleotide Sales by Region
3.4.1 Global Oligonucleotide Sales by Region: 2018 VS 2022 VS 2029
3.4.2 Global Oligonucleotide Sales by Region (2018-2023)
3.4.3 Global Oligonucleotide Sales by Region (2024-2029)
3.4.4 Global Oligonucleotide Sales 麻豆原创 Share by Region (2018-2029)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (excluding China)
3.9 Middle East, Africa and Latin America
4 Competition by Manufactures
4.1 Global Oligonucleotide Sales by Manufacturers
4.1.1 Global Oligonucleotide Sales by Manufacturers (2018-2023)
4.1.2 Global Oligonucleotide Sales 麻豆原创 Share by Manufacturers (2018-2023)
4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Oligonucleotide in 2022
4.2 Global Oligonucleotide Revenue by Manufacturers
4.2.1 Global Oligonucleotide Revenue by Manufacturers (2018-2023)
4.2.2 Global Oligonucleotide Revenue 麻豆原创 Share by Manufacturers (2018-2023)
4.2.3 Global Top 10 and Top 5 Companies by Oligonucleotide Revenue in 2022
4.3 Global Oligonucleotide Sales Price by Manufacturers
4.4 Global Key Players of Oligonucleotide, Industry Ranking, 2021 VS 2022 VS 2023
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers 麻豆原创 Concentration Ratio (CR5 and HHI)
4.5.2 Global Oligonucleotide 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of Oligonucleotide, Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of Oligonucleotide, Product Offered and Application
4.8 Global Key Manufacturers of Oligonucleotide, Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans
5 麻豆原创 Size by Type
5.1 Global Oligonucleotide Sales by Type
5.1.1 Global Oligonucleotide Historical Sales by Type (2018-2023)
5.1.2 Global Oligonucleotide Forecasted Sales by Type (2024-2029)
5.1.3 Global Oligonucleotide Sales 麻豆原创 Share by Type (2018-2029)
5.2 Global Oligonucleotide Revenue by Type
5.2.1 Global Oligonucleotide Historical Revenue by Type (2018-2023)
5.2.2 Global Oligonucleotide Forecasted Revenue by Type (2024-2029)
5.2.3 Global Oligonucleotide Revenue 麻豆原创 Share by Type (2018-2029)
5.3 Global Oligonucleotide Price by Type
5.3.1 Global Oligonucleotide Price by Type (2018-2023)
5.3.2 Global Oligonucleotide Price Forecast by Type (2024-2029)
6 麻豆原创 Size by Application
6.1 Global Oligonucleotide Sales by Application
6.1.1 Global Oligonucleotide Historical Sales by Application (2018-2023)
6.1.2 Global Oligonucleotide Forecasted Sales by Application (2024-2029)
6.1.3 Global Oligonucleotide Sales 麻豆原创 Share by Application (2018-2029)
6.2 Global Oligonucleotide Revenue by Application
6.2.1 Global Oligonucleotide Historical Revenue by Application (2018-2023)
6.2.2 Global Oligonucleotide Forecasted Revenue by Application (2024-2029)
6.2.3 Global Oligonucleotide Revenue 麻豆原创 Share by Application (2018-2029)
6.3 Global Oligonucleotide Price by Application
6.3.1 Global Oligonucleotide Price by Application (2018-2023)
6.3.2 Global Oligonucleotide Price Forecast by Application (2024-2029)
7 US & Canada
7.1 US & Canada Oligonucleotide 麻豆原创 Size by Type
7.1.1 US & Canada Oligonucleotide Sales by Type (2018-2029)
7.1.2 US & Canada Oligonucleotide Revenue by Type (2018-2029)
7.2 US & Canada Oligonucleotide 麻豆原创 Size by Application
7.2.1 US & Canada Oligonucleotide Sales by Application (2018-2029)
7.2.2 US & Canada Oligonucleotide Revenue by Application (2018-2029)
7.3 US & Canada Oligonucleotide Sales by Country
7.3.1 US & Canada Oligonucleotide Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 US & Canada Oligonucleotide Sales by Country (2018-2029)
7.3.3 US & Canada Oligonucleotide Revenue by Country (2018-2029)
7.3.4 U.S.
7.3.5 Canada
8 Europe
8.1 Europe Oligonucleotide 麻豆原创 Size by Type
8.1.1 Europe Oligonucleotide Sales by Type (2018-2029)
8.1.2 Europe Oligonucleotide Revenue by Type (2018-2029)
8.2 Europe Oligonucleotide 麻豆原创 Size by Application
8.2.1 Europe Oligonucleotide Sales by Application (2018-2029)
8.2.2 Europe Oligonucleotide Revenue by Application (2018-2029)
8.3 Europe Oligonucleotide Sales by Country
8.3.1 Europe Oligonucleotide Revenue by Country: 2018 VS 2022 VS 2029
8.3.2 Europe Oligonucleotide Sales by Country (2018-2029)
8.3.3 Europe Oligonucleotide Revenue by Country (2018-2029)
8.3.4 Germany
8.3.5 France
8.3.6 U.K.
8.3.7 Italy
8.3.8 Russia
9 China
9.1 China Oligonucleotide 麻豆原创 Size by Type
9.1.1 China Oligonucleotide Sales by Type (2018-2029)
9.1.2 China Oligonucleotide Revenue by Type (2018-2029)
9.2 China Oligonucleotide 麻豆原创 Size by Application
9.2.1 China Oligonucleotide Sales by Application (2018-2029)
9.2.2 China Oligonucleotide Revenue by Application (2018-2029)
10 Asia (excluding China)
10.1 Asia Oligonucleotide 麻豆原创 Size by Type
10.1.1 Asia Oligonucleotide Sales by Type (2018-2029)
10.1.2 Asia Oligonucleotide Revenue by Type (2018-2029)
10.2 Asia Oligonucleotide 麻豆原创 Size by Application
10.2.1 Asia Oligonucleotide Sales by Application (2018-2029)
10.2.2 Asia Oligonucleotide Revenue by Application (2018-2029)
10.3 Asia Oligonucleotide Sales by Region
10.3.1 Asia Oligonucleotide Revenue by Region: 2018 VS 2022 VS 2029
10.3.2 Asia Oligonucleotide Revenue by Region (2018-2029)
10.3.3 Asia Oligonucleotide Sales by Region (2018-2029)
10.3.4 Japan
10.3.5 South Korea
10.3.6 China Taiwan
10.3.7 Southeast Asia
10.3.8 India
11 Middle East, Africa and Latin America
11.1 Middle East, Africa and Latin America Oligonucleotide 麻豆原创 Size by Type
11.1.1 Middle East, Africa and Latin America Oligonucleotide Sales by Type (2018-2029)
11.1.2 Middle East, Africa and Latin America Oligonucleotide Revenue by Type (2018-2029)
11.2 Middle East, Africa and Latin America Oligonucleotide 麻豆原创 Size by Application
11.2.1 Middle East, Africa and Latin America Oligonucleotide Sales by Application (2018-2029)
11.2.2 Middle East, Africa and Latin America Oligonucleotide Revenue by Application (2018-2029)
11.3 Middle East, Africa and Latin America Oligonucleotide Sales by Country
11.3.1 Middle East, Africa and Latin America Oligonucleotide Revenue by Country: 2018 VS 2022 VS 2029
11.3.2 Middle East, Africa and Latin America Oligonucleotide Revenue by Country (2018-2029)
11.3.3 Middle East, Africa and Latin America Oligonucleotide Sales by Country (2018-2029)
11.3.4 Brazil
11.3.5 Mexico
11.3.6 Turkey
11.3.7 Israel
11.3.8 GCC Countries
12 Corporate Profiles
12.1 Abbott Molecular
12.1.1 Abbott Molecular Company Information
12.1.2 Abbott Molecular Overview
12.1.3 Abbott Molecular Oligonucleotide Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.1.4 Abbott Molecular Oligonucleotide Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Abbott Molecular Recent Developments
12.2 PerkinElmer
12.2.1 PerkinElmer Company Information
12.2.2 PerkinElmer Overview
12.2.3 PerkinElmer Oligonucleotide Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.2.4 PerkinElmer Oligonucleotide Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 PerkinElmer Recent Developments
12.3 SciGene Corporation
12.3.1 SciGene Corporation Company Information
12.3.2 SciGene Corporation Overview
12.3.3 SciGene Corporation Oligonucleotide Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.3.4 SciGene Corporation Oligonucleotide Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 SciGene Corporation Recent Developments
12.4 Roche NimbleGen
12.4.1 Roche NimbleGen Company Information
12.4.2 Roche NimbleGen Overview
12.4.3 Roche NimbleGen Oligonucleotide Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.4.4 Roche NimbleGen Oligonucleotide Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Roche NimbleGen Recent Developments
12.5 CytoTest
12.5.1 CytoTest Company Information
12.5.2 CytoTest Overview
12.5.3 CytoTest Oligonucleotide Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.5.4 CytoTest Oligonucleotide Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 CytoTest Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Oligonucleotide Industry Chain Analysis
13.2 Oligonucleotide Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Oligonucleotide Production Mode & Process
13.4 Oligonucleotide Sales and 麻豆原创ing
13.4.1 Oligonucleotide Sales Channels
13.4.2 Oligonucleotide Distributors
13.5 Oligonucleotide Customers
14 Oligonucleotide 麻豆原创 Dynamics
14.1 Oligonucleotide Industry Trends
14.2 Oligonucleotide 麻豆原创 Drivers
14.3 Oligonucleotide 麻豆原创 Challenges
14.4 Oligonucleotide 麻豆原创 Restraints
15 Key Finding in The Global Oligonucleotide Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Abbott Molecular
PerkinElmer
SciGene Corporation
Roche NimbleGen
CytoTest
听
听
*If Applicable.
